Mycenax Biotech Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
378
- Stock Symbol
-
4726
- Investments
-
1
- Share Price
-
$0.68
- (As of Friday Closing)
Mycenax Biotech General Information
Description
Mycenax Biotech Inc is a Taiwan-based biopharmaceutical company. It is engaged in the development and manufacture of biopharmaceutical products, specializing in mammalian and microbial cell-derived biologics. The company provides services for program evaluation/confirmation, cell line development, and construction, process development technology platforms, drug characterization analysis, the establishment of testing methods, and drug production in accordance with PIC/S GMP manufacturing standards. The company's main operating region is located in Taiwan.
Contact Information
Website
mycenax.comCorporate Office
- 7F, No 66, Shengyi 2nd Road
- Hsinchu County
- Zhubei
- Taiwan
Corporate Office
- 7F, No 66, Shengyi 2nd Road
- Hsinchu County
- Zhubei
- Taiwan
Mycenax Biotech Stock Performance
As of 13-Nov-2026, Mycenax Biotech’s stock price is $0.68. Its current market cap is $141M with 207M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.68 | $0.68 | $0.60 - $1.17 | $141M | 207M | 129K | -$0.06 |
Mycenax Biotech Financials Summary
As of 30-Jun-2026, Mycenax Biotech has a trailing 12-month revenue of $26.3M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 196,456 | 238,299 | 288,939 | 236,995 |
| Revenue | 26,264 | 23,729 | 21,312 | 20,952 |
| EBITDA | (1,499) | (4,463) | (4,518) | (11,545) |
| Net Income | (12,294) | (14,381) | (14,556) | (21,923) |
| Total Assets | 102,810 | 104,281 | 102,432 | 122,702 |
| Total Debt | 35,248 | 34,275 | 26,864 | 23,636 |
Mycenax Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Mycenax Biotech Patents
Mycenax Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020088346-A1 | Aqueous pharmaceutical formulations | Inactive | 31-Oct-2018 | ||
| US-20010026932-A1 | Agonist anti-cd40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents | Active | 01-Feb-2000 | ||
| US-7172759-B2 | Agonist anti-cd40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents | Inactive | 01-Feb-2000 | ||
| US-20070098720-A1 | Bind to cell surface receptor, induce intracellular signal transduction, leading to activation of antigen presenting cells (apc) expressing cd40; cytotoxic effects, useful as antitumor agents | Active | 01-Feb-2000 | ||
| US-7547438-B2 | Bind to cell surface receptor, induce intracellular signal transduction, leading to activation of antigen presenting cells (apc) expressing cd40; cytotoxic effects, useful as antitumor agents | Inactive | 01-Feb-2000 | A61K39/39541 |
Mycenax Biotech Signals
Mycenax Biotech Investments (1)
Mycenax Biotech’s most recent deal was a Joint Venture with Alfenax Biologics. The deal was made on 01-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alfenax Biologics | 01-Dec-2025 | Joint Venture | Drug Discovery |
Mycenax Biotech ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Mycenax Biotech FAQs
-
When was Mycenax Biotech founded?
Mycenax Biotech was founded in 2001.
-
Where is Mycenax Biotech headquartered?
Mycenax Biotech is headquartered in Zhubei, Taiwan.
-
What is the size of Mycenax Biotech?
Mycenax Biotech has 378 total employees.
-
What industry is Mycenax Biotech in?
Mycenax Biotech’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Mycenax Biotech a private or public company?
Mycenax Biotech is a Public company.
-
What is Mycenax Biotech’s stock symbol?
The ticker symbol for Mycenax Biotech is 4726.
-
What is the current stock price of Mycenax Biotech?
As of 13-Nov-2026 the stock price of Mycenax Biotech is $0.68.
-
What is the current market cap of Mycenax Biotech?
The current market capitalization of Mycenax Biotech is $141M.
-
What is Mycenax Biotech’s current revenue?
The trailing twelve month revenue for Mycenax Biotech is $26.3M.
-
What is Mycenax Biotech’s annual earnings per share (EPS)?
Mycenax Biotech’s EPS for 12 months was -$0.06.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process